KR100324907B1 - Stabilized isothiazolone composition from water and ultraviolet rays and method for stabilizing isothiazolone - Google Patents

Stabilized isothiazolone composition from water and ultraviolet rays and method for stabilizing isothiazolone Download PDF

Info

Publication number
KR100324907B1
KR100324907B1 KR1019940032168A KR19940032168A KR100324907B1 KR 100324907 B1 KR100324907 B1 KR 100324907B1 KR 1019940032168 A KR1019940032168 A KR 1019940032168A KR 19940032168 A KR19940032168 A KR 19940032168A KR 100324907 B1 KR100324907 B1 KR 100324907B1
Authority
KR
South Korea
Prior art keywords
isothiazolone
diethylene glycol
weight
composition
dioxane
Prior art date
Application number
KR1019940032168A
Other languages
Korean (ko)
Other versions
KR960016719A (en
Inventor
동은수
김진만
김진배
김승환
Original Assignee
에스케이케미칼주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에스케이케미칼주식회사 filed Critical 에스케이케미칼주식회사
Priority to KR1019940032168A priority Critical patent/KR100324907B1/en
Publication of KR960016719A publication Critical patent/KR960016719A/en
Application granted granted Critical
Publication of KR100324907B1 publication Critical patent/KR100324907B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/22Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing ingredients stabilising the active ingredients

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Toxicology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

PURPOSE: A stabilized isothiazolone composition and a method for stabilizing isothiazolone are provided. The decomposition of isothiazolone having improved antibiotic and antimicrobial activity is effectively inhibited by water and ultraviolet rays without using metal salts. CONSTITUTION: The stabilized isothiazolone composition comprises a 3-isothiazolone compound of free metal represented by the formula(I); a stabilizing agent selected from dioxane and trioxane; and a solvent selected from diethylene glycol, diethylene glycol methyl ether, diethylene glycol dimethyl ether and dipropylene glycol, wherein R1 and R2 are the same or different, and hydrogen, halogen or C1-C4 alkyl; and R3 is hydrogen, halogen atom, C1-C10 alkyl optionally substituted with hydroxy, C2-C10 alkenyl optionally substituted with halogen atom, C2 to C10 alkynyl optionally substituted with halogen atom, or aralkyl optionally substituted with halogen atom, C1-C10 alkyl or C2-C9 alkoxy. The method for stabilizing isothiazolone is characterized by mixing the solvent selected from diethylene glycol, diethylene glycol methyl ether, diethylene glycol dimethyl ether and dipropylene glycol with the 3-isothiazolone compound of free metal represented by the formula(I).

Description

안정화된 이소티아졸론 조성물Stabilized Isothiazolone Composition

본발명은 안정화된 이소티아졸론 조성물에 관한 것으로, 더욱 상세하게는 다음 구조식(I)로 표시되는 이소티아졸론 화합물과 디옥산 또는 트리옥산으로 이루어진 안정화된 3-이소티아졸론 조성물에 관한 것이다.The present invention relates to a stabilized isothiazolone composition, and more particularly to a stabilized 3-isothiazolone composition consisting of an isothiazolone compound represented by the following structural formula (I) and dioxane or trioxane.

상기식에서,In the above formula,

R1및 R2는 각각 서로 같거나 다른 것으로서, 수소원자; 할로겐원자 ; 또는 C1~ C4의 알킬기이고,R 1 and R 2 are the same as or different from each other, and are a hydrogen atom; Halogen atom; Or a C 1 to C 4 alkyl group,

R3는 수소원자 ; 할로겐원자 ; 또는 히드록시기로 치환되거나 치환되지 않은 C1~ C10의 알킬기 ; 할로겐원자로 치환되거나 치환되지 않은 C2~ C10의 알케닐기 ; 할로겐원자로 치환되거나 치환되지 않은 C2~ C10의 알키닐기 ; 할로겐원자, C1~ C10의 알킬기 또는 C2~ C9의 알콕시기로 치환되거나 치환되지 않은 아랄킬기이다.R 3 is a hydrogen atom; Halogen atom; Or a C 1 to C 10 alkyl group unsubstituted or substituted with a hydroxy group; C 2 ~ C 10 alkenyl group unsubstituted or substituted with a halogen atom; C 2 ~ C 10 alkynyl group unsubstituted or substituted with a halogen atom; Or an aralkyl group unsubstituted or substituted with a halogen atom, a C 1 to C 10 alkyl group or a C 2 to C 9 alkoxy group.

이소티아졸론 화합물은 1965년 크라우 등에 의해 개발된 이후, 살균제를 비롯해 도료, 화장품, 섬유 또는 플라스틱 등의 항균 및 항미생물제로써 산업전반에 걸쳐 확대되어 사용되고 있다. 그러나, 이소티아졸론 화합물은 매우 불안정하여 대기중의 습기와 자외선에 의해 쉽게 분해되므로 이소티아졸론 화합물을 첨가시킨 제품의 보관시 그 효과가 감소될 수 있다. 따라서, 이소티아졸론 화합물의 안정성을 향상시키기 위한 다양한 방법들이 연구 개발되어 왔으며, 전형적인 방법은 금속염 안정화제를 사용하는 것이다.Since the isothiazolone compound was developed by Crow et al. In 1965, it has been widely used throughout the industry as an antimicrobial and antimicrobial agent such as disinfectants, paints, cosmetics, textiles or plastics. However, since the isothiazolone compound is very unstable and easily decomposed by moisture and ultraviolet light in the air, its effect may be reduced upon storage of the product to which the isothiazolone compound is added. Therefore, various methods for improving the stability of the isothiazolone compound have been researched and developed, and a typical method is to use a metal salt stabilizer.

그 예로서 미국특허 제3,870,795호 및 제4,067,878호에서는 금속아질산염 또는 금속질산염의 첨가에 의한 화학적 분해에 의해 이소티아졸론 화합물의 안정화를 시도한 바 있으나, 이와같은 금속염 안정화제들은 폴리머가 분산되어 있는 라텍스 에멀젼 수용액에서 에멀젼 성분과 반응하여 응집 현상이니 침전물을 발생시킬 수 있으며, 또한 어떤 시스템에서는 금속염에 결합된 염소이온에 의해 시스템의 부식을 유발시키기도 하므로 이와같은 시스템에서의 금속염 제거는 필수적이다.For example, US Pat. Nos. 3,870,795 and 4,067,878 attempt to stabilize isothiazolone compounds by chemical decomposition by addition of metal nitrites or metal nitrates. Such metal salt stabilizers are latex emulsions in which polymers are dispersed. The removal of metal salts from these systems is essential because they can react with emulsion components in aqueous solutions and cause sedimentation. In some systems, chlorine ions bound to metal salts can cause corrosion of the system.

이에 본 발명의 발명자들은 상기 종래의 이소티아졸론의 안정화 방법에 따른 제반 문제점을 해결하고, 금속염을 사용하지 않는 안정화된 이소티아졸론 시스템을 제공하고자 연구 노력한 결과, 이소티아졸론에 디옥산 또는 트리옥산을 첨가하면 이소티아졸론의 분해를 막을 수 있으리라는 점에 착안하여 본 발명을 완성하였다.Therefore, the inventors of the present invention have solved all the problems according to the stabilization method of the conventional isothiazolone and provide a stabilized isothiazolone system without using a metal salt. As a result, dioxane or trioxane isothiazolone The present invention has been completed by focusing on the fact that the addition of S (a) may prevent decomposition of isothiazolone.

본 발명은 항미생물제로서의 안정화된 3-이소티아졸론 조성물을 제공하는 데 그 목적이 있다.The present invention aims to provide a stabilized 3-isothiazolone composition as an antimicrobial agent.

이하, 본 발명을 상세히 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail.

본발명은 다음 구조식(I)로 표시되는 3-이소티아졸론 화합물과 디옥산 또는 트리옥산, 및 용매로 이루어진 이소티아졸론 조성물을그 특징으로 한다.The present invention is characterized by an isothiazolone composition comprising a 3-isothiazolone compound represented by the following structural formula (I), dioxane or trioxane, and a solvent.

상기식에서 R1,R2및 R3는 상기에서 정의한 바와 같다.Wherein R 1 , R 2 and R 3 are as defined above.

이와같은 본 발명을 더욱 상세히 설명하면 다음과같다.The present invention will be described in more detail as follows.

본 발명은 대기중에 불안정한 3-이소티아졸론 화합물을 안정화시키기 위해 안정화제로서 디옥산 또는 트리옥산을 혼합시킨 이소티아졸론 조성물에 관한 것이다.The present invention relates to an isothiazolone composition in which dioxane or trioxane is mixed as a stabilizer to stabilize an unstable 3-isothiazolone compound in the atmosphere.

본 발명에서 사용될 수 있는 3-이소티아졸론 화합물은 상기 구조식(I)로 표시되는 화합물 중에서 선택된 단독 또는 2종 이상의 혼합물이며, 바람직하기로는 5-클로로-2-메틸-3-이소티아졸론, 2-메틸-3-이소티아졸론, 2-n-옥틸-3-이소티아졸론, 4,5-디클로로-2-시클로헥실-3-이소티아졸론 및 4,5-디클로로-2-n-옥틸-3-이소티아졸론중에서 선택된 단독 또는 2종이상의 혼합물이다. 이중 가장 바람직하기로는 5-클로로-2-메틸-3-이소티아졸론 또는 5-클로로-2-메틸-3-이소티아졸론과 2-메틸-3-이소티아졸론의 혼합물이다. 5-클로로-2-메틸-3-이소티아졸론과 2-메틸-3-이소티아졸론 혼합물의 경우, 바람직한 혼합비는 약 70 : 30 ~ 85 : 15 중량% 이고, 더욱 바람직한 혼합비는 약 70 : 30 ~ 80 : 20 중량%이다. 한편, 2-메틸-3-이소티아졸론이 주성분이고 5-클로로-2-메틸-3-이소티아졸론이 소량 혼합된 혼합물도 매우 바람직한데, 이러한 경우 바람직한 혼합비는 약 98 : 2 ~ 96 : 4 중량%이고, 특히 바람직한 혼합비는 약 97 : 3 중량%이다.The 3-isothiazolone compound which can be used in the present invention is a single or a mixture of two or more selected from the compounds represented by the above formula (I), preferably 5-chloro-2-methyl-3-isothiazolone, 2 -Methyl-3-isothiazolone, 2-n-octyl-3-isothiazolone, 4,5-dichloro-2-cyclohexyl-3-isothiazolone and 4,5-dichloro-2-n-octyl- Single or a mixture of two or more selected from 3-isothiazolones. Most preferred of these are 5-chloro-2-methyl-3-isothiazolone or a mixture of 5-chloro-2-methyl-3-isothiazolone and 2-methyl-3-isothiazolone. In the case of the 5-chloro-2-methyl-3-isothiazolone and 2-methyl-3-isothiazolone mixtures, the preferred mixing ratio is about 70:30 to 85:15 wt%, and more preferred mixing ratio is about 70:30 80: 20 weight%. On the other hand, a mixture of 2-methyl-3-isothiazolone as a main component and a small amount of 5-chloro-2-methyl-3-isothiazolone is also very desirable. In this case, the preferred mixing ratio is about 98: 2 to 96: 4. % By weight, and a particularly preferred mixing ratio is about 97: 3% by weight.

본 발명에서 안정화제로서 사용되는 디옥산 또는 트리옥산의 양은 사용조건 및 혼합물내의 이소티아졸론 농도에 따라 변화될 수 있으며, 효과적인 양은 안정화제 : 이소티아졸론의 혼합비가 1 : 100 ~ 1000 : 1 중량비인 경우이고, 농축용액에서는 1 : 50 ~ 50 : 1 중량비가 일반적이며, 그 이상의 안정화제가 사용될 수도 있으나 이는 비경제적이다. 상당히 희석되어진 3-이소티아졸론용액(용매내 약 1 ~ 10000 ppm 이소티아졸론과 같은 경우)에서는 안정화제 : 이소티아졸론의 비가 약 1 : 10 ~ 20 : 1 중량비이고, 바람직하게는 1 : 5 ~ 20 : 1 중량비이다.The amount of dioxane or trioxane used as a stabilizer in the present invention can be changed depending on the conditions of use and the concentration of isothiazolone in the mixture, and the effective amount is 1: 100 to 1000: 1 weight ratio In a concentrated solution, a weight ratio of 1:50 to 50: 1 is common, and more stabilizers may be used, but this is uneconomical. In a highly diluted 3-isothiazolone solution (such as about 1 to 10000 ppm isothiazolone in the solvent), the ratio of stabilizer to isothiazolone is about 1: 10 to 20: 1 weight ratio, preferably 1: 5 20: 1 weight ratio.

본 발명에 따른 3-이소티아졸론 조성물은 용액의 형태로 제조되는 바, 그 조성비는 상기 구조식(I)로 표시되는 3-이소티아졸론 화합물 중에서 선택된 단독 또는 2종 이상의 혼합물 약 0.01 ~ 99 중량%, 디옥산 또는 트리옥산 0.01 ~ 99 중량% 및 용매 99.98 중량% 이하이고 ; 바람직하기로는 상기 구조식(I)로 표시되는 3-이소티아졸론 화합물 중에서 선택된 단독 또는 2종 이상의 혼합물 0.01 ~ 15 중량%, 디옥산 또는 트리옥산 0.01 ~ 15 중량%, 및 용매 90 ~ 99.98 중량%이고 ; 가장 바람직하기로는 상기 구조식(I)로 표시되는 3-이소티아졸론 화합물중에서 선택된 단독 또는 2종 이상의 혼합물 0.01 ~ 1 중량%, 디옥산 또는 트리옥산 0.01 ~ 1 중량%, 및 용매 98 ~ 99.98 중량%이다.3-isothiazolone composition according to the present invention is prepared in the form of a solution, the composition ratio is about 0.01 to 99% by weight of a single or a mixture of two or more selected from the 3-isothiazolone compound represented by the formula (I) 0.01 to 99% by weight of dioxane or trioxane and 99.98% by weight of solvent; Preferably 0.01 to 15% by weight of a single or two or more mixtures selected from 3-isothiazolone compounds represented by the above formula (I), 0.01 to 15% by weight of dioxane or trioxane, and 90 to 99.98% by weight of a solvent. ; Most preferably, 0.01 to 1% by weight of a single or two or more mixtures selected from 3-isothiazolone compounds represented by the above formula (I), 0.01 to 1% by weight of dioxane or trioxane, and 98 to 99.98% by weight of a solvent to be.

상기와 같은 본 발명의 조성물은 용액의 형태로 제조되며, 그 용도에 따라 농축용액 또는 희석용액으로 제조되고, 대량 선적과 같은 특정 사용의 경우에는 더욱 농축된 용액이 사용될 수 있다.The composition of the present invention as described above is prepared in the form of a solution, depending on the use of the solution is prepared in concentrated or dilute solution, in the case of specific use, such as bulk shipping, a more concentrated solution can be used.

본 발명에서 사용될 수 있는 용매는 이소티아졸론 화합물을 용해시키고, 또한 이를 안정화시킬 수 있는 유기용매라면 어느 것이든 사용 가능하다. 예를들면 글리콜 또는 알콜과 같은 수산기 용매도 사용될 수 있으며, 디옥산 또는 트리옥산에 대한 이소티아졸론의 사용량의 비가 클수록, 그리고 높은 희석조건에서는 글리콜을 사용하면 더욱 효과적이다. 또한, 일련의 조성물에서는 지방족 또는 방향족 탄화수소류가 유용하다. 이외에도 바람직한 용매로는 자유 수산기(free hydroxy)가 에테르 또는 에스테르 작용기로 치환된 폴리올류이며, 이중 특히 바람직하기로는 에틸렌 글리콜 메틸에테르 또는 에틸렌 글리콜 디메틸 에테르이다.The solvent that can be used in the present invention can be used as long as it is an organic solvent that can dissolve and stabilize the isothiazolone compound. Hydroxyl solvents such as, for example, glycols or alcohols may also be used, and the greater the ratio of the amount of isothiazolone to dioxane or trioxane, and the higher the dilution conditions, the more effective the use of glycol. In addition, aliphatic or aromatic hydrocarbons are useful in a series of compositions. In addition, preferred solvents are polyols in which free hydroxy is substituted with an ether or ester functional group, with ethylene glycol methyl ether or ethylene glycol dimethyl ether being particularly preferred.

본 발명에서는 이소티아졸론류의 안정화를 이루는데 단지 소량의 디옥산 또는 트리옥산이 사용될 수 있으며, 이로써 처리될 시스템 내에서의 디옥산 또는 트리옥산의 사용양은 매우 소량이며, 보호가 요구되는 시스템 내의 다른 성분들 또는 보호시스템이 적용되는 시스템을 방해하지 않는다.In the present invention, only a small amount of dioxane or trioxane can be used to achieve stabilization of isothiazolones, so that the amount of dioxane or trioxane in the system to be treated is very small and in a system requiring protection. Other components or protection systems do not interfere with the system to which they are applied.

상기와 같은 본 발명에 따른 이소티아졸론 조성물은 대기중에 매우 안정하여 비교적 장시간 보관하여도 그 약효는 지속되고, 박테리아, 곰팡이, 효모 또는 조류에 의하여 오염되는 어떠한 영역에도 사용이 가능하다.The isothiazolone composition according to the present invention as described above is very stable in the air, and even after being stored for a relatively long time, its medicinal effect persists and can be used in any area contaminated by bacteria, fungi, yeast or algae.

즉, 살균제, 위생제, 청정제, 탈취제, 액체 및 가루비누, 오일 및 그리이스제거제, 음식처리용 화학제품, 일용화학제품, 음식보존제, 동물사료보존제, 목제보존제, 도료, 래주어(lazures), 염색액, 방미제, 병원 및 의료방부제, 금속작업제, 냉각수, 공기청정제, 석유제조시, 종이처리시, 제지공장슬라임방지제, 석유산물,접착제, 섬유, 안료슬러리, 라텍스, 가죽 및 피혁처리, 석유연료, 세탁소독제, 농경배합사료, 잉크, 채광, 부직포, 석유저장소, 호재, 고무, 제당, 담배, 수영장, 화장품, 화장실용품, 풀, 플라스틱, 카드보오드, 의약품, 화학적화장지, 가정세탁물, 디젤연료첨가제, 왁스, 코오크, 윤활제, 건축용품, 콘크리이트배합제 또는 광택제와 기타 바람직하지 않은 미생물이 성장할수 있는 환경과 접촉하는 유기물 및 수분이 있는 영역 어디에나 사용이 가능하다.Ie disinfectants, sanitizers, detergents, deodorants, liquid and powdered soaps, oil and grease removers, food processing chemicals, daily chemicals, food preservatives, animal feed preservatives, wood preservatives, paints, lazures, dyeing Liquids, flavoring agents, hospital and medical preservatives, metal working agents, cooling water, air fresheners, petroleum manufacturing, paper processing, paper mill slime inhibitors, petroleum products, adhesives, textiles, pigment slurry, latex, leather and leather treatment, petroleum Fuel, laundry detergent, agricultural compound feed, ink, mining, non-woven fabric, oil storage, good materials, rubber, sugar, tobacco, swimming pool, cosmetics, toiletries, glue, plastic, card board, pharmaceuticals, chemical toilet paper, household laundry, diesel fuel Use anywhere in areas of organics and moisture that come into contact with the environment where additives, waxes, cokes, lubricants, building supplies, concrete blends or polishes and other undesirable microorganisms can grow. Neunghada.

이하, 본 발명을 실시예에 의거하여 상세히 설명하면 다음과 같은 바, 본 발명이 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail with reference to the following Examples, but the present invention is not limited by the Examples.

모든 퍼센트는 중량%이고 사용되는 모든 시약은 양호한 상태의 공업용 등급의 시약들이다.All percentages are by weight and all reagents used are industrial grade reagents in good condition.

또한, 다음 실시예 1 내지 13 및 비교예 1 내지 9에서 제조된 이소티아졸론 용액은 각각 65℃ 항온조에 방치한후 열안정성을 측정하였으며, 열안정성 측정에 의한 분해정도는 고성능 액체크로마토그래피(HPLC, High Performance Liquid Chromatography)로 측정하였다. 잔류함량(%) 측정결과는 다음 표 1,2 및 3에 나타내었다.In addition, the isothiazolone solution prepared in Examples 1 to 13 and Comparative Examples 1 to 9 was measured for thermal stability after being left in a 65 ° C. thermostatic chamber, respectively, and the degree of decomposition by thermal stability measurement was high performance liquid chromatography (HPLC). , High Performance Liquid Chromatography). Residual content (%) measurement results are shown in the following Tables 1,2 and 3.

실시예 1Example 1

5-클로로-2-메틸-3-이소티아졸론과 2-메틸-3-이소티아졸론이 3 : 1 중량비로 혼합된 이소티아졸론 혼합물 4.5 중량%, 디옥산 9 중량% 및 디에틸렌 글리콜 86.5 중량%를 혼합하여 이소티아졸론 용액을 제조하였다.4.5% by weight isothiazolone mixture with 5-chloro-2-methyl-3-isothiazolone and 2-methyl-3-isothiazolone in a 3: 1 weight ratio, 9% by weight of dioxane and 86.5% by weight of diethylene glycol Mix% to prepare an isothiazolone solution.

실시예 2Example 2

상기 실시예 1과 같은 조성으로 이소티아졸론 용액을 제조하되, 다만 용매로서 디에틸헨 글리콜 86.5 중량% 대신에 디에틸렌 글리콜 메틸 에테르 86.5 중량%를 사용하였다.An isothiazolone solution was prepared in the same composition as in Example 1, except that 86.5 wt% of diethylene glycol methyl ether was used instead of 86.5 wt% of diethylhen glycol as a solvent.

실시예 3Example 3

상기 실시예 1과 같은 조성으로 이소티아졸론 용액을 제조하되, 다만 용매로서 디에틸렌 글리콜 86.5 중량% 대신에 디에틸렌 글리콜 디메틸 에테르 86.5 중량%를 사용하였다.An isothiazolone solution was prepared in the same composition as in Example 1, except that 86.5 wt% of diethylene glycol dimethyl ether was used instead of 86.5 wt% of diethylene glycol as a solvent.

비교예 1Comparative Example 1

5-클로로-2-메틸-3-이소티아졸론과 2-메틸-3-이소티아졸론이 3 : 1 중량비로 혼합된 이소티아졸론 혼합물 4.5 중량% 와 디에틸렌 글리콜 95.5 중량%를 혼합하여 이소티아졸론 용액을 제조하였다.Isothia by mixing 4.5% by weight of an isothiazolone mixture containing 5-chloro-2-methyl-3-isothiazolone and 2-methyl-3-isothiazolone in a 3: 1 weight ratio and 95.5% by weight of diethylene glycol. A jolon solution was prepared.

비교예 2Comparative Example 2

상기 비교예 1과 같은 조성으로 이소티아졸론 용액을 제조하되, 다만 용매로서 디에틸렌 글리콜 95.5 중량% 대신에 애틸렌 글리콜 메틸 에테르 95.5 중량%를 사용하였다.An isothiazolone solution was prepared in the same composition as Comparative Example 1, except that 95.5% by weight of ethylene glycol methyl ether was used instead of 95.5% by weight of diethylene glycol.

비교예 3Comparative Example 3

상기 비교예 1과 같은 조성으로 이소티아졸론 용액을 제조하되, 다만 용매로서 디에틸렌 글리콜 95.5 중량% 대신에 에틸렌 글리콜 디메틸 에테르 95.5 중량%를 사용하였다.An isothiazolone solution was prepared in the same composition as Comparative Example 1, except that 95.5% by weight of ethylene glycol dimethyl ether was used instead of 95.5% by weight of diethylene glycol.

표 1Table 1

실시예 4Example 4

5-클로로-2-메틸-3-이소티아졸론과 2-메틸-3-이소티아졸론이 1 : 5 중량비로 혼합된 이소티아졸론 혼합물 2.5 중량%, 트리옥산 10 중량% 및 디에틸렌 글리콜 87.5 중량%를 혼합하여 이소티아졸론 용액을 제조하였다.2.5% by weight mixture of 5-chloro-2-methyl-3-isothiazolone and 2-methyl-3-isothiazolone in a 1: 5 weight ratio, 10% by weight of trioxane and 87.5% by weight of diethylene glycol Mix% to prepare an isothiazolone solution.

실시예 5Example 5

상기 실시예 4와 같은 조성으로 이소티아졸론 용액을 제조하되, 다만 용매로서 디에틸렌 글리콜 87.5 중량% 대신에 디에틸렌 글리콜 메틸 에테르 87.5 중량%를 사용하였다.An isothiazolone solution was prepared in the same composition as in Example 4, except that 87.5 wt% of diethylene glycol methyl ether was used instead of 87.5 wt% of diethylene glycol as a solvent.

실시예 6Example 6

상기 실시예 4와 같은 조성으로 이소티아졸론 용액을 제조하되, 다만 용매로서 디에틸렌 글리콜 87.5 중량% 대신에 디에틸렌 글리콜 디메틸 에테르 87.5 중량%를 사용하였다.An isothiazolone solution was prepared in the same composition as in Example 4, except that 87.5 wt% of diethylene glycol dimethyl ether was used instead of 87.5 wt% of diethylene glycol as a solvent.

실시예 7Example 7

상기 실시예 4과 같은 조성으로 이소티아졸론 용액을 제조하되, 다만 용매로서 디에틸렌 글리콜 87.5 중량% 대신에 디에틸렌 글리콜 메틸 에테르 45 중량% 와 디프로필렌 글리콜 42.5 중량%를 사용하였다.An isothiazolone solution was prepared in the same composition as in Example 4 except using 45% by weight of diethylene glycol methyl ether and 42.5% by weight of dipropylene glycol instead of 87.5% by weight of diethylene glycol.

실시예 8Example 8

상기 실시예 4와 같은 조성으로 이소티아졸론 용액을 제조하되, 다만 용매로서 디에틸헨 글리콜 87.5 중량% 대신에 디에틸렌 글리콜 디메틸 에테르 45 중량% 와 디프로필랜 글리콜 42.5 중량%를 사용하였다.An isothiazolone solution was prepared in the same composition as in Example 4, except that 45% by weight of diethylene glycol dimethyl ether and 42.5% by weight of dipropyllan glycol were used instead of 87.5% by weight of diethylhen glycol.

비교예 4Comparative Example 4

5-클로로-2-메틸-3-이소티아졸론과 2-메틸-3-이소티아졸론이 1 : 5 중량비로 혼합된 이소티아졸론 혼합물 2.5 중량%와 디에틸렌 글리콜 97.5 중량%를 혼합하여 이소티아졸론 용액을 제조하였다.Isothia by mixing 2.5% by weight of an isothiazolone mixture containing 5-chloro-2-methyl-3-isothiazolone and 2-methyl-3-isothiazolone in a 1: 5 weight ratio and 97.5% by weight of diethylene glycol. A jolon solution was prepared.

비교예 5Comparative Example 5

상기 비교예 4와 같은 조성으로 이소티아졸론 용액을 제조하되, 다만 용매로서 디에틸렌 글리콜 97.5 중량% 대신에 에틸렌 글리콜 메틸 에테르 97.5 중량%를 사용하였다.An isothiazolone solution was prepared in the same composition as Comparative Example 4 except using 97.5 wt% of ethylene glycol methyl ether instead of 97.5 wt% of diethylene glycol as a solvent.

비교예 6Comparative Example 6

상기 비교예 4와 같은 조성으로 이소티아졸론 용액을 제조하되, 다만 용매로서 디에틸렌 글리콜 97.5 중량% 대신에 에틸렌 글리콜 디메틸 에테르 97.5 중량%를 사용하였다.An isothiazolone solution was prepared in the same composition as Comparative Example 4, except that 97.5 wt% of ethylene glycol dimethyl ether was used instead of 97.5 wt% of diethylene glycol as a solvent.

표 2TABLE 2

실시예 9Example 9

5-클로로-2-메틸-3-이소티아졸론과 2-메틸-3-이소티아졸론이 3 : 1 중량비로 혼합된 이소티아졸론 혼합물 14.5 중량%, 디옥산 15 중량% 및 디에틸렌 글리콜 70.5 중량%를 혼합하여 이소티아졸론 용액을 제조하였다.14.5% by weight mixture of 5-chloro-2-methyl-3-isothiazolone and 2-methyl-3-isothiazolone in a 3: 1 weight ratio, 15% by weight of dioxane and 70.5% by weight of diethylene glycol Mix% to prepare an isothiazolone solution.

실시예 10Example 10

상기 실시예 9와 같은조성으로 이소티아졸론 용액을 제조하되, 다만 용매로서 디에틸렌 글리콜 70.5 중량% 대신에 디에틸렌 글리콜 메틸 에테르 70.5 중량%를 사용하였다.An isothiazolone solution was prepared in the same manner as in Example 9, except that 70.5 wt% of diethylene glycol methyl ether was used instead of 70.5 wt% of diethylene glycol as a solvent.

실시예 11Example 11

상기 실시예 9와 같은 조성으로 이소티아졸론 용액을 제조하되, 다만 용매로서 디에틸렌 글리콜 70.5 중량% 대신에 디에틸렌 글리콜 디메틸 에테르 70.5 중량%를 사용하였다.An isothiazolone solution was prepared in the same composition as Example 9, except that 70.5 wt% of diethylene glycol dimethyl ether was used instead of 70.5 wt% of diethylene glycol as a solvent.

실시예 12Example 12

상기 실시예 9와 같은 조성으로 이소티아졸론 용액을 제조하되, 다만 용매로서 디에틸렌 글리콜 70.5 중량% 대신에 디에틸렌 글리콜 메틸 에테르 35 중량% 와 디프로필렌 글리콜 35.5 중량%를 사용하였다.An isothiazolone solution was prepared in the same composition as Example 9, except that 35 wt% diethylene glycol methyl ether and 35.5 wt% dipropylene glycol were used instead of 70.5 wt% of diethylene glycol as a solvent.

실시예 13Example 13

상기 실시예 9와 같은 조성으로 이소티아졸론 용액을 제조하되, 다만 용매로서 디에틸렌 글리콜 70.5 중량% 대신에 디에틸렌 글리콜 디메틸 에테르 35 중량% 와 디프로필렌 글리콜 35.5중량%를 사용하였다.An isothiazolone solution was prepared in the same composition as Example 9, except that 35 wt% diethylene glycol dimethyl ether and 35.5 wt% dipropylene glycol were used instead of 70.5 wt% of diethylene glycol as a solvent.

비교예 7Comparative Example 7

5-클로로-2-메틸-3-이소티아졸론과 2-메틸-3-이소티아졸론이 3 : 1 중량비로 혼합된 이소티아졸론 혼합물 14.5 중량%와 디에틸렌 글리콜 85.5 중량%를 혼합하여 이소티아졸론 용액을 제조하였다.Isothia by mixing 14.5 wt% of an isothiazolone mixture containing 5-chloro-2-methyl-3-isothiazolone and 2-methyl-3-isothiazolone in a 3: 1 weight ratio and 85.5 wt% of diethylene glycol A jolon solution was prepared.

비교예 8Comparative Example 8

상기 비교예 7과 같은 조성으로 이소티아졸론 용액을 제조하되, 다만 용매로서 디에틸렌 글리콜 85.5 중량% 대신에 에틸렌 글리콜 메틸 에테르 85.5 중량%를 사용하였다.An isothiazolone solution was prepared in the same composition as Comparative Example 7, except that 85.5% by weight of ethylene glycol methyl ether was used instead of 85.5% by weight of diethylene glycol.

비교예 9Comparative Example 9

상기 비교예 7과 같은 조성으로 이소티아졸론 용액을 제조하되, 다만 용매로서 디에틸렌 글리콜 85.5 중량% 대신에 에틸렌 글리콜 디메틸 에테르 85.5 중량%를 사용하였다.An isothiazolone solution was prepared in the same composition as Comparative Example 7, except that 85.5% by weight of ethylene glycol dimethyl ether was used instead of 85.5% by weight of diethylene glycol.

표 3TABLE 3

Claims (7)

다음 구조식(I)로 표시되는 유리금속(free metal)의 3-이소티아졸론 화합물; 디옥산 및 트리옥산 중에서 선택된 안정화제; 그리고 디에틸렌 글리콜, 디에틸렌 글리콜 메틸 에테르, 디에틸렌 글리콜 디메틸 에테르 및 디프로필렌 글리콜 중에서 선택된 용매로 이루어진 것임을 특징으로 하는 이소티아졸론 조성물.3-isothiazolone compound of the free metal represented by the following structural formula (I); Stabilizers selected from dioxane and trioxane; And isothiazolone composition, characterized in that consisting of a solvent selected from diethylene glycol, diethylene glycol methyl ether, diethylene glycol dimethyl ether and dipropylene glycol. 상기식에서,In the above formula, R1및 R2는 각각 서로 같거나 다른 것으로서, 수소원자 ; 할로겐원자 ; 또는 C1∼ C4의 알킬기이고,R 1 and R 2 are the same as or different from each other, and a hydrogen atom; Halogen atom; Or a C 1 to C 4 alkyl group, R3는 수소원자 ; 할로겐원자 ; 또는 히드록시기로 치환되거나 치환되지 않은 C1∼ C10의 알킬기 : 할로겐원자로 치환되거나 치환되지 않은 C2∼ C10의 알케닐기 ; 할로겐원자로 치환되거나 치환되지 않은 C2∼ C10의 알키닐기 ; 할로겐원자, C1∼ C10의 알킬기 또는 C2∼ C9의 알콕시기로 치환되거나 치환되지 않은 아랄킬기이다.R 3 is a hydrogen atom; Halogen atom; Or a C 1 to C 10 alkyl group unsubstituted or substituted with a hydroxy group: a C 2 to C 10 alkenyl group unsubstituted or substituted with a halogen atom; C 2 -C 10 alkynyl groups which are unsubstituted or substituted with halogen atoms; Or an aralkyl group unsubstituted or substituted with a halogen atom, a C 1 to C 10 alkyl group, or a C 2 to C 9 alkoxy group. 제 1 항에 있어서, 상기 3-이소티아졸론 화합물은 5-클로로-2-메틸-3-이소티아졸론, 2-메틸-3-이소티아졸론, 2- n-옥틸-3-이소티아졸론, 4,5-디클로로-2-시클로헥실-3-이소티아졸론 및 4,5-디클로로-2- n-옥틸-3-이소티아졸론 중에서 선택된 1종 이상의 것임을 특징으로 하는 이소티아졸론 조성물.The method of claim 1, wherein the 3-isothiazolone compound is 5-chloro-2-methyl-3-isothiazolone, 2-methyl-3-isothiazolone, 2-n-octyl-3-isothiazolone, An isothiazolone composition, characterized in that at least one selected from 4,5-dichloro-2-cyclohexyl-3-isothiazolone and 4,5-dichloro-2-n-octyl-3-isothiazolone. 제 1 항에 있어서, 상기 디옥산 또는 트리옥산과 3-이소티아졸론의 혼합비는 1 : 50 ∼ 20 : 1 중량비임을 특징으로 하는 이소티아졸론 조성물.The isothiazolone composition according to claim 1, wherein the mixing ratio of dioxane or trioxane and 3-isothiazolone is 1: 50-20: 1 by weight. 제 1 항에 있어서, 상기 조성물은 상기 구조식(I)로 표시되는 3-이소티아졸론 화합물 0.01 ∼ 99 중량%, 디옥산 또는 트리옥산 0.01 ∼ 99 중량%, 및 용매 99.98 중량% 이하로 이루어진 것임을 특징으로 하는 이소티아졸론 조성물.According to claim 1, wherein the composition is composed of 0.01 to 99% by weight of the 3-isothiazolone compound represented by the formula (I), 0.01 to 99% by weight of dioxane or trioxane, and 99.98% by weight or less of the solvent. Isothiazolone composition. 안정화 유효량의 디옥산 또는 트리옥산과, 디에틸렌 글리콜, 디에틸렌 글리콜 메틸 에테르, 디에틸렌 글리콜 디메틸 에테르 및 디프로필렌 글리콜 중에서 선택된 용매를 다음 구조식(I)로 표시되는 유리금속(free metal)의 3-이소티아졸론 화합물에 혼합시키는 것을 특징으로 하는 이소티아졸론의 안정화방법.A stabilized effective amount of dioxane or trioxane, and a solvent selected from diethylene glycol, diethylene glycol methyl ether, diethylene glycol dimethyl ether, and dipropylene glycol are selected from 3- of the free metal represented by the following structural formula (I): A method for stabilizing isothiazolones, which is mixed with an isothiazolone compound. 상기식에서, R1, R2및 R3는 상기 1항에서 정의한 바와 같다.Wherein R 1 , R 2 and R 3 are as defined in claim 1 above. 제 5 항에 있어서, 상기 디옥산 또는 트리옥산과 3-이소티아졸론의 혼합비가 1 : 100 내지 1000 : 1 중량비임을 특징으로 하는 안정화방법.The method of claim 5, wherein the mixing ratio of the dioxane or trioxane and 3-isothiazolone is 1: 100 to 1000: 1 by weight ratio. 상기 제 1 항의 이소티아졸론 조성물이 유효성분으로 함유된 것임을 특징으로 하는 항미생물제.Antimicrobial agent, characterized in that the isothiazolone composition of claim 1 contained as an active ingredient.
KR1019940032168A 1994-11-30 1994-11-30 Stabilized isothiazolone composition from water and ultraviolet rays and method for stabilizing isothiazolone KR100324907B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019940032168A KR100324907B1 (en) 1994-11-30 1994-11-30 Stabilized isothiazolone composition from water and ultraviolet rays and method for stabilizing isothiazolone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019940032168A KR100324907B1 (en) 1994-11-30 1994-11-30 Stabilized isothiazolone composition from water and ultraviolet rays and method for stabilizing isothiazolone

Publications (2)

Publication Number Publication Date
KR960016719A KR960016719A (en) 1996-06-17
KR100324907B1 true KR100324907B1 (en) 2004-12-17

Family

ID=37478123

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940032168A KR100324907B1 (en) 1994-11-30 1994-11-30 Stabilized isothiazolone composition from water and ultraviolet rays and method for stabilizing isothiazolone

Country Status (1)

Country Link
KR (1) KR100324907B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100615571B1 (en) * 1999-12-31 2006-08-25 에스케이케미칼주식회사 Composition treating water for inhibiting growth of microorganism and scale

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02250805A (en) * 1989-03-24 1990-10-08 Osamu Umekawa Industrial bactericide

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02250805A (en) * 1989-03-24 1990-10-08 Osamu Umekawa Industrial bactericide

Also Published As

Publication number Publication date
KR960016719A (en) 1996-06-17

Similar Documents

Publication Publication Date Title
US5142058A (en) Halogen-containing organic stabilizers for 3-isothiazolones
JPH0818932B2 (en) Stabilized isothiazolone composition
KR100756456B1 (en) Stabilized microbicide formulation
US5049677A (en) Bismuth salt stabilizers for 3-isothiazolones
EP1084619B1 (en) Stable biocidal compositions
JPH04221374A (en) Method for stabilizing 3-isothiazolone
US5424324A (en) Use of carbonyl stabilizers for 3-isothiazolones
US5242893A (en) Use of hexamethylenetetramine as a stabilizer for 3-isothiazolones
JP2923129B2 (en) Bromate stabilizers for 3-isothiazolones
IL96354A (en) Stabilized 3-isothiazolone compositions containing carbonyl compounds
KR0179359B1 (en) The use of hexamethylenetetramine as a stabilizer for 3-isothiazolones
KR0151951B1 (en) Stabilized isothiazolone microbicidal compositions
US5145981A (en) Use of antimony salt stabilizers for 3-isothiazolones
KR100324907B1 (en) Stabilized isothiazolone composition from water and ultraviolet rays and method for stabilizing isothiazolone
KR100313665B1 (en) Stabilized isothiazolone composition
US5118699A (en) Use of hydrazide stabilizers for 3-isothiazolones
KR100385714B1 (en) A stabilized isothiazolone composition and method of stabilization of isothiazolone
KR100217309B1 (en) Stabilized isothiazolone solution
JP2981865B2 (en) Stabilized isothiazolone solution
KR100324908B1 (en) Stabilized 3-isothiazolone solution from water and ultraviolet rays and method for stabilizing isothiazolone
KR20010103525A (en) A method inhibiting precipitation of isothiazolone solution and a composition the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120127

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20130121

Year of fee payment: 12

LAPS Lapse due to unpaid annual fee